Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 6, 2011, Pages 1864-1872

  Hoefig, Carolin S ^a   Köhrle, Josef ^a   Brabant, Georg ^b   Dixit, Kashinath ^b   Yap, Beng ^b   Strasburger, Christian J ^a   Wu, Zida ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 IODOTHYRONAMINE; LEVOTHYROXINE; LIOTHYRONINE; MONOCLONAL ANTIBODY; RADIOACTIVE IODINE; THYROGLOBULIN; THYROID HORMONE; THYROID HORMONE DERIVATIVE; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER PATIENT; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; EXPLORATORY RESEARCH; FEMALE; FREEZE THAWING; HORMONE DETERMINATION; HUMAN; HYPOPITUITARISM; IMMUNOASSAY; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; ROOM TEMPERATURE; STORAGE TEMPERATURE; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROID HORMONE SYNTHESIS; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CHEMILUMINESCENT MEASUREMENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPOPITUITARISM; MALE; MIDDLE AGED; THYROID HORMONES; THYROID NEOPLASMS; THYRONINES;

EID: 79956319556     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2680     Document Type: Article

References (33)

1. Liggett SB 2004 The two-timing thyroid. Nat Med 10:582-583 (Pubitemid 38796845)
2. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascarelli S, Crossley DA, Bunzow JR, Ronca-Testoni S, Lin ET, Hatton D, Zucchi R, Grandy DK 2004 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 10:638-642 (Pubitemid 38796856)
3. Piehl S, Hoefig CS, Scanlan TS, Köhrle J 2011 Thyronamines: past, present, and future. Endocr Rev 32:64-80
4. Dratman MB 1974 On the mechanism of action of thyroxin, an amino acid analog of tyrosine. J Theor Biol 46:255-270
5. Oetting A, Yen PM 2007 New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab 21:193-208 (Pubitemid 46888201)
6. Saba A, Chiellini G, Frascarelli S, Marchini M, Ghelardoni S, Raffaelli A, Tonacchera M, Vitti P, Scanlan TS, Zucchi R 2010 Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology 151:5063-5073
7. Braulke LJ, Klingenspor M, DeBarber A, Tobias SC, Grandy DK, Scanlan TS, Heldmaier G 2008 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation. J Comp Physiol B 178:167-177 (Pubitemid 351164900)
8. Chiellini G, Frascarelli S, Ghelardoni S, Carnicelli V, Tobias SC, DeBarber A, Brogioni S, Ronca-Testoni S, Cerbai E, Grandy DK, Scanlan TS, Zucchi R 2007 Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function. FASEB J 21: 1597-1608 (Pubitemid 46684861)
9. Zucchi R, Ghelardoni S, Chiellini G 2010 Cardiac effects of thyronamines. Heart Fail Rev 15:171-176
10. Dhillo WS, Bewick GA, White NE, Gardiner JV, Thompson EL, Bataveljic A, Murphy KG, Roy D, Patel NA, Scutt JN, Armstrong A, Ghatei MA, Bloom SR 2009 The thyroid hormone derivative 3-iodothyronamine increases food intake in rodents. Diabetes Obes Metab 11:251-260
11. Klieverik LP, Foppen E, Ackermans MT, Serlie MJ, Sauerwein HP, Scanlan TS, Grandy DK, Fliers E, Kalsbeek A 2009 Central effects of thyronamines on glucose metabolism in rats. J Endocrinol 201: 377-386
12. Regard JB, Kataoka H, Cano DA, Camerer E, Yin L, Zheng YW, Scanlan TS, Hebrok M, Coughlin SR 2007 Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J Clin Invest 117:4034-4043 (Pubitemid 350224112)
13. Scanlan TS 2009 Minireview: 3-Iodothyronamine (T1AM): a new player on the thyroid endocrine team? Endocrinology 150:1108-1111
14. 1AM): a new chapter of thyroid hormone endocrinology? Mol Biosyst 6:1338-1344
15. Axelband F, Dias J, Ferrão F, Einicker-Lamas M 2011 Nongenomic signaling pathways triggered by thyroid hormones and their metabolite 3-iodothyronamine on the cardiovascular system. J Cell Physiol 226:21-28
16. Stathatos N, Wartofsky L 2003 The euthyroid sick syndrome: is there a physiologic rationale for thyroid hormone treatment? J Endocrinol Invest 26:1174-1179
17. Hesch RD 1981 ["Low T3" syndrome]. Dtsch Med Wochenschr 106:971-972 (German)
18. Kaptein EM, Beale E, Chan LS 2009 Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. J Clin Endocrinol Metab 94:3663-3675
19. Wartofsky L, Burman KD 1982 Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome." Endocr Rev 3:164-217
20. Soldin O, Gu J, Soldin SJ, Thyronamines: tandem mass spectrometry quantification in biological fluids. Program of the 80th Annual Meeting of the American Thyroid Association, Palm Beach, FL, 2009, Poster Short Call Poster 37, p S-114 (Abstract)
21. Geraci T, Fjeld C, Colasurdo V, Samuels M, Schuff K, Scanlan T 3-Iodothyronamine (T1AM) levels in human serum and tissue. Program of the 79th Annual Meeting of the American Thyroid Association, Chicago, IL, 2008, Short call oral presentation number 1 (Abstract)
22. DeBarber AE, Geraci T, Colasurdo VP, Hackenmueller SA, Scanlan TS 2008 Validation of a liquid chromatography-tandem mass spectrometry method to enable quantification of 3-iodothyronamine from serum. J Chromatogr A 1210:55-59
23. Ackermans MT, Klieverik LP, Ringeling P, Endert E, Kalsbeek A, Fliers E 2010 An online solid-phase extraction-liquid chromatography-tandem mass spectrometry method to study the presence of thyronamines in plasma and tissue and their putative conversion from 13C6-thyroxine. J Endocrinol 206:327-334
24. Soldin OP, Soldin SJ 2011 Thyroid hormone testing by tandem mass spectrometry. Clin Biochem 44:89-94
25. Piehl S, Heberer T, Balizs G, Scanlan TS, Smits R, Koksch B, Köhrle J 2008 Thyronamines are isozyme-specific substrates of deiodinases. Endocrinology 149:3037-3045 (Pubitemid 351724541)
26. Gompf HS, Greenberg JH, Aston-Jones G, Ianculescu AG, Scanlan TS, Dratman MB 2010 3-Monoiodothyronamine: the rationale for its action as an endogenous adrenergic-blocking neuromodulator. Brain Res 1351:130-140
27. Jonklaas J, Kahric-Janicic N, Soldin OP, Soldin SJ 2009 Correlations of free thyroid hormones measured by tandem mass spectrometry and immunoassay with thyroid-stimulating hormone across 4 patient populations. Clin Chem 55:1380-1388
28. Köhler G, Milstein C 1975 Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497
29. Chopra LJ, Sabatino L 2000 Nature and sources of circulating thyroid hormones. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott Williams, Wilkins; 121-135
30. Scanlan TS, Thyronamines: beyond T4 and T3. Plenary Lecture 4. European Congress of Endocrinology, Prague, Czechoslovakia, 2010
31. Hoefig CS, Schlärmann P, Piehl S, Bertoldi M, Scanlan TS, Schweizer U, Köhrle J, Towards the identification of iodothyronine decarboxylases. Program of the 34th Annual Meeting of the European Thryoid Association, Lisbon, Portugal, P138, 2009, p 227
32. Hettinger BG, Schuff K, Scanlan T, Pharmacokinetics of 3-Iodothyronamine in mice. Program of the 80th Annual Meeting of the American Thyroid Association, Palm Beach, FL, 2009, Poster Short Call Poster 36, p S-114 (Abstract)
33. Corcoran JM, Eastman CJ 1983 Radioimmunoassay of 3-L-monoiodothyronine: application in normal human physiology and thyroid disease. J Clin Endocrinol Metab 57:66-70 (Pubitemid 13065446)